[{"abstract": "A publication sponsored by Merck and including positive articles about its products comes to light in a lawsuit alleging misleading and deceptive practices.", "web_url": "https://www.nytimes.com/2009/05/14/business/14vioxxside.html", "snippet": "A publication sponsored by Merck and including positive articles about its products comes to light in a lawsuit alleging misleading and deceptive practices.", "lead_paragraph": "Pharmaceutical companies routinely offer doctors reprints of articles from medical journals that are favorable to their products.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Merck Paid for Medical \u2018Journal\u2019 Without Disclosure", "kicker": null, "content_kicker": null, "print_headline": "Merck Paid for Medical \u2018Journal\u2019 Without Disclosure", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Reed Elsevier N.V", "rank": 2, "major": "N"}, {"name": "subject", "value": "Vioxx (Drug)", "rank": 3, "major": "N"}], "pub_date": "2009-05-14T00:58:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Natasha Singer", "person": [{"firstname": "Natasha", "middlename": null, "lastname": "Singer", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/cd4980fc-025b-5e23-87d0-c00de9d5599b", "word_count": 475, "uri": "nyt://article/cd4980fc-025b-5e23-87d0-c00de9d5599b"}, {"abstract": "A class-action lawsuit over the strategies that Merck used to market its painkiller Vioxx in Australia is earning the American drug maker some bad publicity.", "web_url": "https://www.nytimes.com/2009/05/14/business/14vioxx.html", "snippet": "A class-action lawsuit over the strategies that Merck used to market its painkiller Vioxx in Australia is earning the American drug maker some bad publicity.", "lead_paragraph": "Australians have been riveted over the last month by a class-action lawsuit that is pulling back the curtain on strategies that the American drug giant Merck used in its international marketing of the painkiller Vioxx.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [], "headline": {"main": "Trial Puts Spotlight on Merck", "kicker": null, "content_kicker": null, "print_headline": "Trial Puts Spotlight On Merck", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Vioxx (Drug)", "rank": 2, "major": "N"}, {"name": "glocations", "value": "Australia", "rank": 3, "major": "N"}, {"name": "subject", "value": "ADVERTISING AND MARKETING", "rank": 4, "major": "N"}, {"name": "subject", "value": "Suits and Litigation", "rank": 5, "major": "N"}], "pub_date": "2009-05-14T01:00:38+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Natasha Singer", "person": [{"firstname": "Natasha", "middlename": null, "lastname": "Singer", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/56137b64-4eff-5f2c-b2a8-46a91e61a7bc", "word_count": 1081, "uri": "nyt://article/56137b64-4eff-5f2c-b2a8-46a91e61a7bc"}]